ArticleMuscle & nerve2022

Assessment timing and choice of outcome measure in determining treatment response in chronic inflammatory demyelinating polyneuropathy: A post hoc analysis of the PRISM trial.

Yusuf A Rajabally et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.